Frequently Asked Questions
The COVID-19 pandemic is an unparalleled global public health challenge and is expected to harm the body composition analyzers market.
North America accounted for the most heightened share in the global body composition analyzers market.
The rising prevalence of lifestyle disorders, increased focus on research and development proficiencies in medical devices, and the adoption of advanced healthcare technologies are major factors driving the market.
The bio-impedance analyzers segment had a major share in the global market in 2021.
The fitness centers component had a major share in the global market in 2021 and is anticipated to continue during the forecast period.